TCL Archive FDA examining endpoints for approval of cancer therapies, potential departure from survival as the gold standard, Oncology Division Director Richard Pazdur says in interview. November 7, 2003
TCL Archive Science Policy: All’s Well In Access to Trials, GAO Study Finds; NIH Disagrees November 5, 1999
